A class action lawsuit has been filed against Kyverna Therapeutics for misleading investors during its February 2024 IPO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback